A new study has put a name to something many women on a GLP-1 already feel in their bodies: the quiet sense that they should keep the medication a secret. Researchers from Rice University, the Mayo Clinic, and UCLA found a clear pattern of GLP-1 stigma and judgment. People who lost weight using a medication like Ozempic, Wegovy, Mounjaro, or Zepbound were judged more harshly than people who lost the same weight through diet and exercise. On some measures, they were judged more harshly than people who did not lose weight at all.
What happened
The study, published in the International Journal of Obesity and reported by Rice University on 4 May 2026, ran two randomised experiments with 1,313 US participants. Each person read a short description of a fictional individual and then rated them. The only thing that changed between groups was how that person had managed their weight: with a GLP-1 (the generic name is a glucagon-like peptide-1 receptor agonist, semaglutide or tirzepatide), through diet and exercise, or not at all.
Lead author Erin Standen, an assistant professor of psychological sciences at Rice, expected some bias. The size of it surprised her. "There's a narrative that using these medications is taking the easy way out," she said, "and that belief seems to shape how people are judged." The team also found that anyone who regained weight was rated more negatively, whether the loss first came from a medication or a diet.
Why this judgment is really diet culture in disguise
Read the finding plainly and the logic falls apart. Weight loss is supposed to be the goal. Yet the people who reached it with medical help were punished for the method. That is not a verdict on health. It is the old diet-culture belief that weight loss only counts if you suffered for it, dressed up in concern.
GLP-1 medications act on appetite, blood sugar, and the gut. They are tools, the way insulin and statins are tools. A woman who quiets her food noise with a prescription has not cheated. She has used medicine for a medical condition, often alongside the harder, less visible work of protecting her muscle with strength training and eating enough protein. The "easy way out" story erases all of that.
What it means for you
If you have felt you must hide your pen, this study is permission to stop carrying that weight. The judgment is real, but it is not yours to absorb. It belongs to the person making it.
A few steadying truths. Your worth was never tied to a number on the scale, and it is certainly not tied to how you reached it. The most important things you are building are the ones no one can see: preserved lean muscle, steadier energy, a calmer relationship with food. Stigma also has a cost the researchers flagged, which is that it can quietly stop people from speaking openly with their prescriber. Do not let it. Your appointments are yours, and honesty there protects you. If the shame is wearing on your mood, that is worth naming too, because GLP-1 medications and emotional health are more connected than most people expect.
What Steady does with this
Steady treats your medication as a normal, private fact of your health, never something to apologise for. The app tracks what actually matters across the month, the muscle you keep, the symptoms you carry, the steadiness you build, and turns it into one clear page you can hand to a prescriber. The scale is the least interesting number here. What you keep is the real story, and it is nobody else's to judge.
